Medicine recalls
|
| |
| Canada: Three lots of antidiuretic DDAVP Spray recalled because of potential overdose risk |
| |
Health Canada announces that Ferring Inc. is recalling three lots of DDAVP Spray (desmopressin acetate nasal solution, 10 micrograms/spray) because the product may contain a higher than labelled dose of the active ingredient (desmopressin) and could pose an overdose risk. The affected products are:
- DDAVP Spray, 2.5 ml (lot number: R11524L and S10153C)
- DDAVP Spray, 5 ml (lot number: R14720C)
Taking too much desmopressin may cause headache, nausea, vomiting, abdominal cramps, facial flushing and weight gain because of water retention and, in severe cases, convulsions.
Please refer to the following website in Health Canada for details:
http://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/../73567a-eng.php
In Hong Kong, Minirin Nasal Spray 0.1mg/ml (HK-30498) is a registered pharmaceutical product containing desmopressin acetate. The product is registered by Ferring Pharmaceuticals Ltd (Ferring), and is a prescription-only medicine. As confirmed with Ferring, the above product is currently not marketed in Hong Kong. Related news was previously issued by Singapore Health Sciences Authority and the United Kingdom Medicines and Healthcare products Regulatory Agency, and was posted on the Drug Office website on 15 Jul 2020 and 16 Jul 2020 respectively.
Ends/Friday, Jul 17, 2020
Issued at HKT 15:00
|
| |
|
